This is a standard board appointment with no financial or strategic catalyst. No trading action warranted. Monitor the next quarterly report for any operational or pipeline updates.
Price Chart
Executive Summary
Jupiter Neurosciences appointed Dr. Tomas J. Philipson, a health economist with former senior U.S. government roles (Acting Chairman of the Council of Economic Advisers), to its board, effective June 26, 2026. He was also placed on the Audit and Compensation Committees. In lieu of cash compensation, he receives options to purchase a total of 536,428 shares, vesting quarterly over three years. This is a routine board addition with no change in executive leadership or financials — neutral for the stock.
Key Facts
- Tomas J. Philipson, Ph.D., appointed to the board effective June 26, 2026.
- He also joins the Audit and Compensation Committees.
- Equity compensation: sign-on option for 90,000 shares + annual retainer/committee option for 446,428 shares, both vesting quarterly over 36 months.
- All compensation in options (no cash retainer/fees) at FMV on grant date.
- No other arrangements or transactions requiring disclosure under Item 404(a).
Financial Impact
Options cover 536,428 shares total; exercise price equals FMV as of June 29, 2026. No cash compensation or expense disclosed beyond standard grant.
Risk Factors
- Potential dilution from the 536,428 option shares over 3 years; however, this is modest given the micro-cap market cap of ~$10M.
- No material change to the business outlook.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-031312 |
| Document: 0001493152-26-031312-index-headers.html | 0001493152-26-031312 |
| Document: 0001493152-26-031312-index.html | 0001493152-26-031312 |
| Document: 0001493152-26-031312.txt | 0001493152-26-031312 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | SC 13G/A | $2.88 | awaiting T+5 | — | $2.64 (−8.33%) |
Sep 24, 2026 4w ago | S-3 | $2.67 $2.55 | ▲ +4.49% | ▲ +4.27% | $2.64 (+1.12%) |
Sep 22, 2026 5w ago | SC 13G | $2.98 $2.58 | ▼ −13.42% | ▼ −12.24% | $2.64 (−11.41%) |
Aug 28, 2026 8w ago | 8-K | $3.54 $3.08 | ▲ +12.99% | ▲ +12.85% | $2.64 (+25.42%) |
Aug 27, 2026 8w ago | 8-K | $4.89 $3.26 | ▲ +33.33% | ▲ +33.60% | $2.64 (+46.01%) |
Aug 24, 2026 9w ago | 8-K | $5.17 $3.35 | ▲ +35.20% | ▲ +34.66% | $2.64 (+48.94%) |
Aug 24, 2026 9w ago | 8-K | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.64 (+53.36%) |
Aug 24, 2026 9w ago | 424B5 | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.64 (+53.36%) |
Jul 27, 2026 13w ago | 8-K | $0.1135 $0.1000 | ▲ +11.89% | ▲ +14.41% | $2.64 (−2225.99%) |
Jul 21, 2026 14w ago | Press Release | $0.1697 $0.1097 | ▼ −35.36% | ▼ −34.36% | $2.64 (+1455.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers